Suppr超能文献

从物种中鉴定有效且专一的抗糖尿病药物分子。

Identification of Effective and Nonpromiscuous Antidiabetic Drug Molecules from Species.

作者信息

Saleem Shahzad, Bibi Shabana, Yousafi Qudsia, Hassan Tehzeem, Khan Muhammad Saad, Hasan Mohammad Mehedi, Chopra Hitesh, Moustafa Mahmoud, Al-Shehri Mohammed, Khalid Mohammad, Kabra Atul

机构信息

COMSATS University Islamabad, Sahiwal Campus, Sahiwal, Pakistan.

Department of Biological Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

出版信息

Evid Based Complement Alternat Med. 2022 Jun 8;2022:7040547. doi: 10.1155/2022/7040547. eCollection 2022.

Abstract

Diabetes mellitus (DM) is a very common metabolic disorder/disease. The deterioration of -cells by autoimmune system is the hallmark of this disease. Thioredoxin-Interacting Protein (TXNIP) is responsible for -cells degradation by T-cells in the pancreas. This protein had been declared a good drug target for controlling DM. Lots of side effects have been reported as a result of long-time consumption of conventional antidiabetic drugs. The development of new and effective drugs with the minimal side effects needs time. TXNIP was selected as a target for Computer-Aided Drug Design. The antidiabetic fungal metabolite compounds were selected from the literature. The compounds were screened for their drug-likeness properties by DruLiTo and DataWarior tools. Twenty-two drug-like fungal compounds were subjected to Quantitative Structure-Activity Relationship (QSAR) analysis by using CheS-Mapper 2.0. The lowest (0.01) activity cliff was found for three compounds: Pinazaphilone A, Pinazaphilone B, and Chermesinone A. The highest value for apol (81.76) was shown by Asperphenamate, while Albonoursin and Sterenin L showed highest score (40.66) for bpol. The lowest value (0.46) for fractional molecular frame (FMF) was calculated for Pinazaphilone A and Pinazaphilone B. TPSA for Pinazaphilone A and Pinazaphilone B was 130.51 Å. log   < 5 was observed for all the twenty-two compounds. Molecular docking of fungal compounds with TXNIP was done by AutoDock Vina. The binding energy for complexes ranged between -9.2 and -4.6 kcal/mol. Four complexes, TXNIP-Pinazaphilone A, TXNIP-Pinazaphilone B, TXNIP-Asperphenamate, and TXNIP-Sterenin L, were selected for MD simulation to find out the best lead molecule. Only one complex, TXNIP-Pinazaphilone B, showed a stable conformation throughout the 80 ns run of MD simulation. Pinazaphilone B derived from the species fungi was selected as the lead molecule for development of antidiabetic drug having the least side effects.

摘要

糖尿病(DM)是一种非常常见的代谢紊乱/疾病。自身免疫系统对β细胞的破坏是这种疾病的标志。硫氧还蛋白相互作用蛋白(TXNIP)负责胰腺中T细胞对β细胞的降解。这种蛋白质已被宣布为控制糖尿病的良好药物靶点。长期服用传统抗糖尿病药物已报告有许多副作用。开发副作用最小的新型有效药物需要时间。TXNIP被选为计算机辅助药物设计的靶点。从文献中选择抗糖尿病真菌代谢物化合物。通过DruLiTo和DataWarior工具筛选这些化合物的类药性质。使用CheS-Mapper 2.0对22种类药真菌化合物进行定量构效关系(QSAR)分析。发现三种化合物:匹那扎菲隆A、匹那扎菲隆B和赭曲霉酮A的活性悬崖最低(0.01)。曲霉酸显示apol的最高值(81.76),而阿尔波诺菌素和硬脂菌素L显示bpol的最高得分(40.66)。计算得出匹那扎菲隆A和匹那扎菲隆B的分数分子框架(FMF)最低值(0.46)。匹那扎菲隆A和匹那扎菲隆B的拓扑极性表面积(TPSA)为130.51 Å。所有22种化合物的log P均<5。通过AutoDock Vina对真菌化合物与TXNIP进行分子对接。复合物的结合能在-9.2至-4.6 kcal/mol之间。选择四种复合物,TXNIP-匹那扎菲隆A、TXNIP-匹那扎菲隆B、TXNIP-曲霉酸和TXNIP-硬脂菌素L进行分子动力学(MD)模拟,以找出最佳先导分子。在80 ns的MD模拟运行中,只有一种复合物TXNIP-匹那扎菲隆B显示出稳定的构象。从真菌物种中提取的匹那扎菲隆B被选为开发副作用最小的抗糖尿病药物的先导分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ce/9200499/412e5cc1beeb/ECAM2022-7040547.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验